2 months ago
42
Health leaders have warned Britons are facing some of the “most severe” shortages of NHS medicines on record, including common painkillers, epilepsy drugs and HRT.
The National Pharmacy Association (NPA) has warned that medicine shortages pose a “serious risk to patient safety”.
While the Middle East conflict has made supply chains more volatile, it is not the only factor driving shortages, the NPA said.
Lack of ingredients, manufacturing disruption, the UK’s smaller medicines budget compared with other EU countries, and, in the case of HRT, changing prescribing habits have all played a part.
We would like to hear whether you have experienced any shortages of your NHS medication. What has happened? How are you coping?
Share your experience
You can share your thoughts in the form below or by messaging us. We will get back to you before we publish any of your submission.
Your responses, which can be anonymous, are secure as the form is encrypted and only the Guardian has access to your contributions. We will only use the data you provide us for the purpose of the feature and we will delete any personal data when we no longer require it for this purpose. For alternative ways to get in touch securely please see our
Tell us a bit about yourself (e.g. age, background, what you do)
Optional
Have you experienced any shortages of your NHS medication? What has happened and how have you coped?
Please include as much detail as possible.
You can share other concerns here
Optional
Please include as much detail as possible.
If you are happy to, please upload a photo of yourself here
Optional
Please note, the maximum file size is 5.7 MB.
Choose file
Your contact details are helpful so we can contact you for more information. They will only be seen by the Guardian.
Your contact details are helpful so we can contact you for more information. They will only be seen by the Guardian.
You can add more information here
Optional
If you include other people's names please ask them first.
By submitting your response, you are agreeing to share your details with us for this feature.
